All recommendations within this article are informed by expert editorial opinion. If you click on a link in this story we may earn affiliate revenue. THE viral Asda leopard print coat is dubbed ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

Recently, viral Chinese hair stylist Long Shu took to Xiaohongshu to share that he and his female friend were checking in at the airport when they were told that they couldn't bring spray gel onboard.

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

All products are independently selected by our editors. If you buy something, we may earn an affiliate commission. Tailored jackets are a keystone species in the menswear ecosystem, but there’s ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

This winter style was first introduced in the 1950s. The second lady’s embrace of the look will boost its popularity anew One of the upsides of living on an island at 55.3781 degrees latitude is ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...